Immunotherapeutic Advances for NSCLC-Reference-Cited by-同舟云学术

Immunotherapeutic Advances for NSCLC

Published:2021-10 Issue: Volume:Volume 15 Page:399-417
ISSN:1177-5491
Container-title:Biologics: Targets and Therapy
language:en
Short-container-title:BTT

Author:

Massafra Marco,Passalacqua Maria Ilenia^ORCID,Gebbia Vittorio,Macrì Paolo,Lazzari Chiara,Gregorc Vanesa,Buda Carmelo,Altavilla Giuseppe,Santarpia Mariacarmela

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Gastroenterology,Oncology,Rheumatology,Immunology and Allergy

Reference110 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

3. Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

4. First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress

5. Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review;Cancers;2024-06-26

2. Single-cell and bulk RNA sequencing data jointly reveals VDAC2’s impacts on prognosis and immune landscape of NSCLC;Aging;2024-02-20

3. Analysis of cellular response to drugs with a microfluidic single-cell platform based on hyperspectral imaging;Analytica Chimica Acta;2024-02

4. Low-dose SAHA enhances CD8+T cell-mediated antitumor immunity by upregulating MHC I expression in non-small cell lung cancers;2023-12-06

5. Construction of a genomic instability-derived predictive prognostic signature for non-small cell lung cancer patients;Cancer Genetics;2023-11